🇬🇧 UK Medical Licensing Assessment (UKMLA) · subject

UK Medical Licensing Assessment (UKMLA) Professional Knowledge, Ethics and the Practising Doctor Syllabus

The Professional Knowledge, Ethics and the Practising Doctor syllabus for UK Medical Licensing Assessment (UKMLA) in full: 6 chapters, 28 topics and 78 sub-topics, every one listed below, plus 63 Professional Knowledge, Ethics and the Practising Doctor flashcards with answers.

6Chapters
28Topics
78Sub-topics
63Flashcards

Professional Knowledge, Ethics and the Practising Doctor syllabus: all 6 chapters

Expand any chapter to see its topics and sub-topics.

  1. Professional Values and Behaviours

    4 topics
    • Good Medical Practice duties of a doctor
      • Knowledge, skills and performance
      • Safety and quality
      • Communication, partnership and teamwork
      • Maintaining trust and integrity
    • Professional identity and the doctor-patient relationship
      • Trust, honesty and acting with integrity
      • Maintaining professional boundaries
      • Conflicts of interest and accepting gifts
    • Maintaining and demonstrating competence
      • Recognising and working within the limits of competence
      • Appraisal, revalidation and continuing professional development
      • Keeping accurate clinical records
    • Health, wellbeing and fitness to practise of the doctor
      • Managing stress, burnout and fatigue
      • Self-treatment and registering with a GP
      • Bloodborne virus and notifiable illness obligations
  2. Medical Ethics and the Law

    6 topics
    • Core ethical principles and frameworks
      • Autonomy, beneficence, non-maleficence and justice
      • Duty-based and consequentialist reasoning
      • Distributive justice and resource allocation
    • Confidentiality and information governance
      • Duty of confidentiality and its limits
      • Disclosures in the public interest
      • Data protection and Caldicott principles
      • Statutory disclosures and notifiable diseases
    • Consent to treatment
      • Valid consent: capacity, information and voluntariness
      • Montgomery and the standard for material risk
      • Consent in emergencies and the doctrine of necessity
      • Refusal of treatment and advance decisions
    • Mental capacity and decision-making
      • Mental Capacity Act 2005 and the two-stage test
      • Best interests decisions
      • Lasting power of attorney and court-appointed deputies
      • Deprivation of Liberty Safeguards
    • End-of-life ethics
      • Withholding and withdrawing treatment
      • Do Not Attempt CPR decisions and ReSPECT
      • Doctrine of double effect
      • Euthanasia and assisted dying: the legal position
    • Consent and capacity in children
      • Gillick competence and Fraser guidelines
      • Parental responsibility and disputes
      • Refusal of treatment by minors
  3. Safeguarding and Vulnerable Groups

    5 topics
    • Safeguarding children
      • Recognising physical, emotional and sexual abuse and neglect
      • Fabricated or induced illness
      • Referral pathways and information sharing
    • Safeguarding adults at risk
      • Types of adult abuse including financial and institutional
      • Domestic abuse and coercive control
      • Modern slavery and human trafficking
    • Female genital mutilation
      • Mandatory reporting duty
      • Risk assessment and referral
    • Radicalisation and the Prevent duty
    • Recognising and responding to deprivation and inequality
  4. Patient Safety, Quality Improvement and Governance

    5 topics
    • Human factors and systems thinking in error
      • Swiss cheese model and latent errors
      • Never events
      • Situational awareness and cognitive bias
    • Incident reporting and learning
      • Duty of candour
      • Significant event analysis and root cause analysis
      • Open disclosure and apology
    • Quality improvement methodology
      • Plan-Do-Study-Act cycles
      • Clinical audit versus research versus service evaluation
      • Measurement for improvement and run charts
    • Clinical governance and regulation
      • Roles of the CQC, GMC and NICE
      • Whistleblowing and raising concerns
      • Risk management and the safety thermometer
    • Medication safety and prescribing errors
  5. Evidence-Based Medicine and Research

    4 topics
    • Study design and hierarchy of evidence
      • Randomised controlled trials, cohort and case-control studies
      • Systematic reviews and meta-analysis
      • Bias, confounding and randomisation
    • Critical appraisal and statistics
      • Sensitivity, specificity and predictive values
      • Relative and absolute risk, NNT and odds ratios
      • P-values, confidence intervals and statistical power
    • Screening principles
      • Wilson and Jungner criteria
      • Lead-time and length-time bias
      • National screening programmes
    • Research ethics and governance
      • Informed consent in research
      • Research ethics committees and the Declaration of Helsinki
      • Conflicts of interest in publication
  6. Public Health and Health Promotion

    4 topics
    • Determinants of health and health inequalities
      • Social, economic and environmental determinants
      • Inverse care law
      • Health needs assessment
    • Epidemiology of disease
      • Incidence, prevalence and mortality measures
      • Outbreak investigation
      • Surveillance and notifiable diseases
    • Health behaviour change and promotion
      • Brief interventions and motivational interviewing
      • Smoking cessation, alcohol and weight management
      • Immunisation principles and the UK schedule
    • Global and environmental health
      • Climate change and sustainable healthcare
      • Antimicrobial resistance as a public health threat

UK Medical Licensing Assessment (UKMLA) Professional Knowledge, Ethics and the Practising Doctor flashcards — 63 questions with answers

  1. What are the four domains of the GMC's 'Good Medical Practice' framework for the duties of a doctor?

    1) Knowledge, skills and development (formerly 'Knowledge, skills and performance'); 2) Patients, partnership and communication; 3) Colleagues, culture and safety; 4) Trust and professionalism.

  2. According to Good Medical Practice, what overriding principle must guide a doctor's clinical decisions?

    Make the care of your patient your first concern. The doctor must act in the patient's best interests, provide a good standard of practice and care, and protect and promote the health of patients and the public.

  3. What is meant by 'professionalism' and the formation of a professional identity in medicine?

    It is the internalisation of the values, behaviours and relationships that underpin public trust in doctors — acting with integrity, honesty, compassion and accountability — so that one thinks, acts and feels like a physician, not just performs the role.

  4. What is the duty of candour, and distinguish its professional and statutory forms?

    The duty to be open and honest with patients when something goes wrong. Professional duty of candour (GMC/NMC) applies to individuals for any harm or near miss; statutory duty (Health and Social Care Act 2008, Reg 20) applies to organisations and is triggered by a notifiable safety incident causing moderate/severe harm, prolonged psychological harm, or death.

  5. How must a doctor maintain and demonstrate competence under GMC requirements?

    By keeping knowledge and skills up to date through continuing professional development (CPD), working within the limits of competence, taking part in annual appraisal, collecting supporting information, and undergoing revalidation every 5 years to retain a licence to practise.

  6. What are the components of GMC revalidation in the UK?

    A licensed doctor revalidates every 5 years based on annual appraisals supported by: CPD, quality improvement activity, significant events, feedback from colleagues, feedback from patients, and review of complaints and compliments. A Responsible Officer makes the revalidation recommendation.

  7. What should a doctor do regarding their own health if they may pose a risk to patients (fitness to practise)?

    Register with a GP, not self-diagnose or self-prescribe, seek and follow independent professional advice, and not rely on their own assessment of the risk. If they have a serious condition that could be passed to patients, they must take advice and act on it to protect patients.

  8. Define 'fitness to practise' as used by the GMC.

    A doctor's suitability to be on the medical register without restrictions. It can be impaired by misconduct, deficient performance, ill health, a criminal conviction/caution, or a determination by another regulatory body.

  9. Name the four core principles ('four pillars') of biomedical ethics (Beauchamp and Childress).

    Autonomy (respect for self-determination), Beneficence (act in the patient's best interest), Non-maleficence (do no harm), and Justice (fair distribution of benefits, risks and resources).

  10. Contrast deontological and consequentialist (utilitarian) ethical frameworks.

    Deontology judges acts by adherence to duties/rules and the inherent rightness of the act regardless of outcome (e.g. never lie). Consequentialism judges acts by their outcomes, aiming to maximise overall good (the greatest good for the greatest number).

  11. What is the doctrine of double effect?

    An action with a good intended effect (e.g. relieving pain) may be permissible even if it has a foreseen but unintended harmful effect (e.g. hastening death), provided the harmful effect is not the means to the good effect, the act is proportionate, and the intention is good.

  12. State the general legal and ethical rule on patient confidentiality and its main justifications.

    Information shared in confidence must not be disclosed without consent. Justified by respect for autonomy, the implied contract of the doctor-patient relationship, and the public interest in patients trusting doctors enough to seek care.

  13. List circumstances in which a doctor may disclose confidential patient information without consent.

    When required by law/statute (e.g. notifiable diseases, FGM in under-18s, court order), and when justified in the public interest where the benefit (preventing serious harm/crime) outweighs the patient's and public interest in confidentiality. Disclosure should be the minimum necessary.

  14. What are the Caldicott Principles concerned with, and name the role that safeguards them?

    They govern the use and sharing of confidential patient/service-user information (e.g. justify the purpose, use the minimum necessary, access on a need-to-know basis, and that the duty to share can be as important as the duty to protect). The Caldicott Guardian is the senior person responsible for protecting patient information in an organisation.

  15. Under UK GDPR/Data Protection Act 2018, what is the lawful basis category for health data and who can access records?

    Health data is 'special category' personal data requiring an additional condition (e.g. provision of health care, vital interests). Patients have a right of access (subject access request) to their own records, and access must follow the data protection principles (lawfulness, minimisation, accuracy, security).

  16. What three elements must all be present for consent to treatment to be valid?

    1) Capacity (the patient is able to make the decision); 2) Voluntariness (the decision is free from coercion or undue influence); 3) Information (the patient is given sufficient, relevant information). Consent must be ongoing and can be withdrawn.

  17. What standard of information disclosure for consent was established by Montgomery v Lanarkshire (2015)?

    Doctors must disclose any material risks — those a reasonable person in the patient's position would attach significance to, or that this particular patient would. It replaced the doctor-centred Bolam test for consent with a patient-centred standard of material risk.

  18. State the five principles of the Mental Capacity Act 2005 (England and Wales).

    1) Presume capacity. 2) Support people to make their own decisions before deeming them unable. 3) An unwise decision does not equal lack of capacity. 4) Act in the person's best interests if they lack capacity. 5) Choose the least restrictive option of their rights and freedoms.

  19. What is the two-stage test for assessing mental capacity under the MCA 2005?

    Stage 1 (diagnostic): Is there an impairment of, or disturbance in, the functioning of the mind or brain? Stage 2 (functional): Because of it, is the person unable to do one of: Understand the information, Retain it, Use/weigh it, or Communicate the decision? Capacity is decision- and time-specific.

  20. What is an Advance Decision to Refuse Treatment (ADRT) and what is required for it to refuse life-sustaining treatment?

    A legally binding decision made by a person with capacity to refuse specified treatment in future when they lack capacity. To refuse life-sustaining treatment it must be in writing, signed, witnessed, and contain a clear statement that it applies even if life is at risk.

Show the other 43 Professional Knowledge, Ethics and the Practising Doctor flashcards
  1. Distinguish a Lasting Power of Attorney for health from best-interests decision-making.

    A health and welfare LPA lets a chosen attorney make decisions (including, if specified, about life-sustaining treatment) once the person loses capacity. Without a valid ADRT or LPA, the clinical team makes a best-interests decision considering the person's past wishes, feelings, beliefs and the views of those close to them.

  2. In end-of-life ethics, distinguish euthanasia, assisted suicide, and withdrawal of treatment.

    Euthanasia: a doctor deliberately ends a patient's life (illegal in the UK, murder/manslaughter). Assisted suicide: helping a person end their own life (illegal under the Suicide Act 1961). Withdrawing/withholding futile or unwanted treatment that is not in the patient's best interests is lawful and is not euthanasia.

  3. Who can consent to treatment for a child under 16 in England, and what is Gillick competence?

    A child under 16 can consent if Gillick competent — having sufficient maturity and understanding to fully appreciate the proposed treatment. Otherwise a person with parental responsibility (or the court) consents. The treatment must still be in the child's best interests.

  4. What are Fraser guidelines used for?

    They set the criteria for providing contraceptive/sexual health advice and treatment to a person under 16 without parental consent: the young person understands the advice; cannot be persuaded to inform parents; is likely to have intercourse with or without treatment; their physical/mental health would suffer without it; and treatment is in their best interests.

  5. Can a competent young person's refusal of life-saving treatment be overridden in England?

    Yes. While a competent young person can consent, a refusal of treatment by a 16-17 year old (or Gillick-competent younger child) can be overridden by a person with parental responsibility or the court if treatment is in their best interests — refusal is treated differently from consent.

  6. Name the four categories of child abuse for safeguarding purposes.

    Physical abuse, emotional (psychological) abuse, sexual abuse, and neglect. (Neglect is the most common category and a persistent failure to meet a child's basic physical and/or psychological needs.)

  7. What features of an injury or presentation should raise suspicion of non-accidental injury (NAI) in a child?

    Injury inconsistent with the history or developmental stage; delayed presentation; changing/implausible explanations; injuries in non-mobile infants; specific patterns (e.g. torn frenulum, retinal haemorrhages, metaphyseal/posterior rib fractures, bruising of unusual sites/shapes); and disclosure by the child.

  8. What is the legal definition of a 'child' for safeguarding, and what duty do all professionals share?

    A child is anyone under 18 years (Children Act 1989/2004). Safeguarding is everyone's responsibility; concerns must be acted upon, recorded, and shared with the local safeguarding lead/children's social care, and the child's welfare is the paramount consideration.

  9. Define an 'adult at risk' (vulnerable adult) under the Care Act 2014.

    An adult who has needs for care and support (whether or not the authority is meeting them), is experiencing or at risk of abuse or neglect, and as a result of those needs is unable to protect themselves against the abuse, neglect or risk of it.

  10. List the categories of abuse recognised in adult safeguarding under the Care Act 2014.

    Physical, sexual, psychological/emotional, financial/material, neglect/acts of omission, discriminatory, organisational/institutional, domestic, modern slavery, and self-neglect.

  11. What is the law and the doctor's mandatory reporting duty regarding female genital mutilation (FGM) in the UK?

    FGM is illegal (FGM Act 2003, amended 2015). Regulated health/social-care professionals and teachers have a mandatory personal duty to report to the police any case where a girl under 18 discloses she has had FGM, or where they observe physical signs of FGM in a girl under 18.

  12. What is the Prevent duty and a doctor's role in relation to radicalisation?

    Prevent is part of the UK's CONTEST counter-terrorism strategy. Specified authorities, including the NHS, have a statutory duty to have 'due regard to the need to prevent people being drawn into terrorism'. Clinicians should recognise vulnerability to radicalisation as a safeguarding concern and refer concerns (e.g. to a Prevent lead/Channel panel).

  13. What is the 'inverse care law'?

    Proposed by Julian Tudor Hart: the availability of good medical care tends to vary inversely with the need of the population served — those who most need care are least likely to receive it, an effect more marked where care is exposed to market forces.

  14. Define health inequalities and the 'social gradient' in health.

    Health inequalities are unfair, avoidable differences in health across populations and social groups. The social gradient means health worsens stepwise as socioeconomic position falls — it is not just the poorest versus everyone else, but a continuous gradient across all of society.

  15. What is the difference between the 'person approach' and the 'system approach' to error (human factors)?

    The person approach blames individuals for forgetfulness/carelessness and targets the 'sharp end'. The system approach (Reason) accepts that humans are fallible and errors are consequences of conditions in the system; it focuses on building defences and changing conditions rather than blaming people.

  16. Explain Reason's 'Swiss cheese model' of accident causation.

    Defences against error are like slices of Swiss cheese with holes (latent conditions and active failures). An accident occurs only when the holes in successive layers momentarily line up, allowing a hazard to pass through all defences to cause harm. Holes are dynamic, opening and shifting.

  17. Distinguish active failures from latent conditions in error analysis.

    Active failures are unsafe acts by people at the sharp end (slips, lapses, mistakes, violations) with immediate effects. Latent conditions are upstream organisational/design weaknesses (understaffing, poor equipment, fatigue-inducing rotas) that lie dormant and predispose the system to error.

  18. Classify human errors into the main types (slips, lapses, mistakes, violations).

    Slips: actions not carried out as intended (execution error of a skilled action). Lapses: memory failures (omitting a step). Mistakes: errors of intention/planning (rule-based or knowledge-based). Violations: deliberate deviations from safe procedures (routine, optimising, or necessary/situational).

  19. What is a root cause analysis (RCA) and when is it used?

    A structured retrospective method for investigating serious patient safety incidents to identify the underlying system causes (not individuals) and contributory factors, generating recommendations to prevent recurrence. In the NHS it is being succeeded by the Patient Safety Incident Response Framework (PSIRF).

  20. What are the seven pillars (components) of clinical governance?

    Clinical effectiveness/research, audit, risk management, education and training, patient/public involvement, using information/IT, and staffing & staff management. (It is the framework through which organisations are accountable for continuously improving quality of care.)

  21. Describe the clinical audit cycle.

    A quality improvement cycle: 1) Identify problem and set standards/criteria; 2) Measure current practice against the standard; 3) Compare results with the standard; 4) Implement change; 5) Re-audit to close the loop and confirm improvement. It compares practice against an explicit standard.

  22. Contrast clinical audit with research.

    Research creates new generalisable knowledge ('what should we do?'), may involve randomisation/experimentation, and needs ethics committee approval. Audit measures whether current practice meets an already-established standard ('are we doing what we should?'), changes nothing experimentally, and does not require ethics approval.

  23. What is the Plan-Do-Study-Act (PDSA) cycle in quality improvement?

    A small-scale iterative method for testing change: Plan (the change and predictions), Do (test it on a small scale and collect data), Study (analyse results vs prediction), Act (adopt, adapt or abandon). Multiple ramped PDSA cycles build evidence for scaling up a successful change.

  24. What is a 'never event' in patient safety?

    A serious, largely preventable patient safety incident that should not occur if available preventative measures are implemented (e.g. wrong-site surgery, retained foreign object post-procedure, wrong-route administration of medication). They require investigation and reporting.

  25. Name common categories of prescribing/medication error and a key system safeguard against them.

    Errors include wrong drug, dose, route, frequency, patient, omission, and interactions/allergies. Safeguards: electronic prescribing with decision support, the 'five rights' (right patient, drug, dose, route, time), allergy documentation, double-checking high-risk drugs, and reconciliation at transitions of care.

  26. Rank the hierarchy of evidence from strongest to weakest study designs.

    From top to bottom: Systematic reviews/meta-analyses of RCTs > Randomised controlled trials > Cohort studies > Case-control studies > Cross-sectional studies > Case series/case reports > Expert opinion/background information.

  27. Contrast cohort and case-control study designs.

    Cohort: prospective, groups defined by exposure status and followed to measure incidence of outcome; yields relative risk; good for rare exposures, poor for rare outcomes. Case-control: retrospective, groups defined by outcome (cases vs controls) and compared for past exposure; yields odds ratio; good for rare outcomes/long latency, prone to recall and selection bias.

  28. Define sensitivity, specificity, and write the formulas.

    Sensitivity = proportion of true positives correctly identified: $\text{Sens} = \frac{TP}{TP+FN}$. Specificity = proportion of true negatives correctly identified: $\text{Spec} = \frac{TN}{TN+FP}$. A highly sensitive test rules out (SnNOut); a highly specific test rules in (SpPIn).

  29. Define positive and negative predictive value and state how they depend on prevalence.

    $PPV = \frac{TP}{TP+FP}$ (probability disease present given a positive test); $NPV = \frac{TN}{TN+FN}$ (probability disease absent given a negative test). Unlike sensitivity/specificity, predictive values depend on disease prevalence: as prevalence falls, PPV falls and NPV rises.

  30. Define relative risk, absolute risk reduction, and number needed to treat.

    Relative risk $RR = \frac{\text{risk in exposed}}{\text{risk in unexposed}}$. Absolute risk reduction $ARR = |\text{risk}_{control} - \text{risk}_{treatment}|$. Number needed to treat $NNT = \frac{1}{ARR}$ — the number of patients treated to prevent one additional adverse outcome.

  31. What does a p-value represent and what is the conventional significance threshold?

    The p-value is the probability of obtaining results at least as extreme as those observed if the null hypothesis were true. Conventionally $p < 0.05$ is deemed statistically significant. It does not measure effect size or the probability that the hypothesis is true.

  32. Interpret a 95% confidence interval, including for a ratio measure.

    A 95% CI is the range within which the true population value is expected to lie 95% of the time on repeated sampling; narrower intervals indicate greater precision. For a ratio (RR or OR), if the CI crosses 1 the result is not statistically significant; for a difference, if it crosses 0 it is not significant.

  33. Distinguish Type I and Type II statistical errors.

    Type I error (α, false positive): rejecting a true null hypothesis — concluding an effect exists when it does not. Type II error (β, false negative): failing to reject a false null hypothesis — missing a real effect. Statistical power $= 1 - \beta$, the probability of detecting a true effect.

  34. State the Wilson and Jungner principles for a screening programme.

    Key criteria: the condition is an important health problem with a recognisable latent/early stage and understood natural history; there is an acceptable, safe, valid test; an effective, accepted treatment exists with agreed policy on whom to treat; facilities for diagnosis/treatment are available; and screening is cost-effective and a continuing process.

  35. Define lead-time and length-time bias in screening.

    Lead-time bias: screening detects disease earlier, so survival time from diagnosis appears longer even if death occurs at the same time (no true benefit). Length-time bias: screening preferentially detects slow-growing, less aggressive disease (which spends longer in the detectable phase), overstating the apparent benefit.

  36. What are the requirements for valid research ethics and governance in the UK?

    Voluntary informed consent, favourable Research Ethics Committee (REC) approval, Health Research Authority (HRA) approval, adherence to Good Clinical Practice and the Declaration of Helsinki, independent scientific review, data protection, and provisions for participant safety, confidentiality and the right to withdraw.

  37. What four principles underpin the ethics of human research participation (per the Declaration of Helsinki/Belmont)?

    Respect for persons (informed, voluntary consent and protection of those with reduced autonomy), beneficence and non-maleficence (favourable risk-benefit balance), and justice (fair selection of participants and equitable distribution of burdens/benefits). The wellbeing of the participant takes precedence over the interests of science and society.

  38. Distinguish incidence from prevalence and give their relationship.

    Incidence: number of NEW cases arising in a population at risk over a time period (measures risk). Prevalence: total number of EXISTING cases at a point/period (measures burden). Relationship: $\text{Prevalence} \approx \text{Incidence} \times \text{average duration of disease}$.

  39. Define the basic reproduction number $R_0$ and the herd immunity threshold.

    $R_0$ is the average number of secondary cases produced by one infectious case in a fully susceptible population. An epidemic spreads if $R_0 > 1$. The herd immunity threshold (proportion that must be immune to halt spread) is $1 - \frac{1}{R_0}$.

  40. Distinguish the main categories of bias and confounding in epidemiology.

    Selection bias: systematic error in how participants are chosen/retained. Information (measurement) bias: error in measuring exposure/outcome (e.g. recall, observer bias). Confounding: a third factor associated with both exposure and outcome that distorts the apparent relationship (controlled by randomisation, restriction, matching, stratification or multivariable adjustment).

  41. Name the stages of the Transtheoretical (Stages of Change) model of behaviour change.

    Precontemplation, Contemplation, Preparation, Action, and Maintenance (with relapse as a possible part of the cycle). Interventions should be tailored to the patient's current stage.

  42. Describe the determinants of health using the Dahlgren-Whitehead 'rainbow' model.

    Layered influences on health: 1) fixed individual factors (age, sex, genetics) at the core; surrounded by 2) individual lifestyle factors; 3) social and community networks; 4) living and working conditions (housing, education, employment, healthcare, food); and 5) general socioeconomic, cultural and environmental conditions.

  43. What is the concept of 'planetary health' / environmental determinants of health, with an example relevant to medicine?

    Planetary health recognises that human health depends on the health of natural systems; climate change and environmental degradation are major threats (heat-related illness, vector-borne disease spread, air-pollution respiratory/cardiovascular disease, food/water insecurity). The healthcare sector is also a significant carbon emitter, motivating sustainable ('green') clinical practice.

UK Medical Licensing Assessment (UKMLA) Professional Knowledge, Ethics and the Practising Doctor FAQ

What is in the UK Medical Licensing Assessment (UKMLA) Professional Knowledge, Ethics and the Practising Doctor syllabus?

UK Medical Licensing Assessment (UKMLA) Professional Knowledge, Ethics and the Practising Doctor is split into 6 chapters: Professional Values and Behaviours, Medical Ethics and the Law, Safeguarding and Vulnerable Groups, Patient Safety, Quality Improvement and Governance, Evidence-Based Medicine and Research and Public Health and Health Promotion. Together they contain 28 topics and 78 sub-topics.

How many chapters are in UK Medical Licensing Assessment (UKMLA) Professional Knowledge, Ethics and the Practising Doctor?

6 chapters, containing 28 topics and 78 sub-topics. The largest chapter is Medical Ethics and the Law, with 6 topics.

Are there flashcards for UK Medical Licensing Assessment (UKMLA) Professional Knowledge, Ethics and the Practising Doctor?

Yes — a 63-card Professional Knowledge, Ethics and the Practising Doctor deck, printed in full in the flashcards section of this page and available in the Examius app with spaced repetition. The free plan covers one exam of your choice, including its flashcards; Examius Pro, a one-time purchase, unlocks every other exam and deck.